DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans

被引：277

作者：

Chen, Minjun ^{[1
]}

Suzuki, Ayako ^{[2
]}

Thakkar, Shraddha ^{[1
]}

Yu, Ke ^{[1
]}

Hu, Chuchu ^{[1
]}

Tong, Weida ^{[1
]}

机构：

[1] US FDA, Div Bioinformat & Biostat, Natl Ctr Toxicol Res, Jefferson, AR USA

[2] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA

来源：

DRUG DISCOVERY TODAY | 2016年 / 21卷 / 04期

关键词：

ORAL MEDICATIONS; HEPG2; CELLS; HEPATOTOXICITY; MODELS; TOXICITY; PHARMACEUTICALS; LIPOPHILICITY; STRATEGY; DATABASE;

D O I：

10.1016/j.drudis.2016.02.015

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

[No abstract available]

引用

页码：648 / 653

页数：6

共 46 条

[1]

Human Drug-Induced Liver Injury Severity Is Highly Associated With Dual Inhibition of Liver Mitochondrial Function and Bile Salt Export Pump [J].

Aleo, Michael D. ;

Luo, Yi ;

Swiss, Rachel ;

Bonin, Paul D. ;

Potter, David M. ;

Will, Yvonne .

HEPATOLOGY, 2014, 60 (03) :1015-1022

[2]

Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].

Andrade, RJ ;

Lucena, MI ;

Fernández, MC ;

Pelaez, G ;

Pachkoria, K ;

García-Ruiz, E ;

García-Munoz, B ;

González-Grande, R ;

Pizarro, A ;

Durán, JA ;

Jiménez, M ;

Rodrigo, L ;

Romero-Gomez, M ;

Navarro, JM ;

Planas, R ;

Costa, J ;

Borras, A ;

Soler, A ;

Salmerón, J ;

Martin-Vivaldi, R .

GASTROENTEROLOGY, 2005, 129 (02) :512-521

[3]

[Anonymous], 2014, SYST BIOL

[4]

Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans [J].

Atienzar, Franck A. ;

Novik, Eric I. ;

Gerets, Helga H. ;

Parekh, Amit ;

Delatour, Claude ;

Cardenas, Alvaro ;

MacDonald, James ;

Yarmush, Martin L. ;

Dhalluin, Stephane .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 275 (01) :44-61

[5]

Categorization of Drugs Implicated in Causing Liver Injury: Critical Assessment Based on Published Case Reports [J].

Bjornsson, Einar S. ;

Hoofnagle, Jay H. .

HEPATOLOGY, 2016, 63 (02) :590-603

[6]

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study [J].

Chalasani, Naga ;

Bonkovsky, Herbert L. ;

Fontana, Robert ;

Lee, William ;

Stolz, Andrew ;

Talwalkar, Jayant ;

Reddy, K. Rajendar ;

Watkins, Paul B. ;

Navarro, Victor ;

Barnhart, Huiman ;

Gu, Jiezhun .

GASTROENTEROLOGY, 2015, 148 (07) :1340-+

[7]

The Liver Toxicity Knowledge Base: A Systems Approach to a Complex End Point [J].

Chen, M. ;

Zhang, J. ;

Wang, Y. ;

Liu, Z. ;

Kelly, R. ;

Zhou, G. ;

Fang, H. ;

Borlak, J. ;

Tong, W. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (05) :409-412

[8]

Predicting idiosyncratic drug-induced liver injury - some recent advances [J].

Chen, Minjun ;

Borlak, Juergen ;

Tong, Weida .

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) :721-723

[9]

A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model [J].

Chen, Minjun ;

Tung, Chun-Wei ;

Shi, Qiang ;

Guo, Lei ;

Shi, Leming ;

Fang, Hong ;

Borlak, Jurgen ;

Tong, Weida .

ARCHIVES OF TOXICOLOGY, 2014, 88 (07) :1439-1449

[10]

Toward predictive models for drug-induced liver injury in humans: are we there yet? [J].

Chen, Minjun ;

Bisgin, Halil ;

Tong, Lillian ;

Hong, Huixiao ;

Fang, Hong ;

Borlak, Juergen ;

Tong, Weida .

BIOMARKERS IN MEDICINE, 2014, 8 (02) :201-213

← 1 2 3 4 5 →